Oct. 11] THE NEW ZEALAND GAZETTE 1493

SCHEDULE

APPROXIMATE area of the piece of land required to be taken: 10 acres.
Being part Rural Section 11180, and being the whole of the land
comprised and described in certificate of title, Volume 406,
flio 240 (Canterbury Land Registry).

Situated in Block II, Waipara Survey District (Canterbury
R.D.).

In the Canterbury Land District; as the same is more parti-
cularly delineated on the plan marked P.W.D. 135240, deposited
in the office of the Minister of Works at Wellington, and thereon
edged red.

As witness my hand at Wellington, this 3rd day of October
1951.

W. S. GOOSMAN, Minister of Works.

(P.W. 53/687. D.O. 37/99)

The Drug Tariff (September 1946) Amendment No. 13

PURSUANT to section 90 of the Social Security Act 1938, the
Minister of Health hereby issues the following direction:—

1. (1) This direction may be cited as the Drug Tariff (September
   1946), Amendment No. 13, and shall be read together with and
   deemed part of the Drug Tariff (September 1946),* (hereinafter
   referred to as the principal direction).

(2) This direction shall come into force on the 1st day of
November 1951, except where otherwise specified.

2. Clause 4 of the principal direction is hereby amended as
   follows:—

(a) By revoking the definition of the term “B.P.”, and
substituting the following definition:—

“‘B.P.’ means the 1948 edition of the British
Pharmacopoeia, together with the monographs set out
in pages 1 to 71 inclusive of the Addendum 1951 to the
British Pharmacopoeia 1948:”:

(b) By revoking the definition of the term “B.P.C.”, and
substituting the following definition:—

“‘B.P.C.’ means the general monographs in Part I
and the preparations included in Part VI (the Formulary
Section) of the British Pharmaceutical Codex 1949,
together with amendments thereto in existence at the
1st day of September 1951.”

3. The following materials are hereby added to the table of
   materials unconditionally excluded under paragraph (a) of clause 5
   of the principal direction:—

Chloramphenicol (Chloromycetin),
Ointments, creams, and similar preparations containing
Oestrone, Oestradiol Dipropionate, Oestradiol Benzoate,
Ointments, creams, and similar preparations containing any
antihistamine.

4. Part 1 of the Addendum dated September 1946, to the
   New Zealand Formulary is hereby amended by omitting the
   materials listed in the table of materials allowed under paragraph (b)
   of clause 5 of the principal direction, and substituting the following
   materials:—

Adrenaline Mucate for administration by injection,
Adrenaline Tartrate,
Antazoline Hydrochloride,
Antitoxin (Diphtheria),
Antitoxin (Tetanus),
Benedict’s Solution (qualitative),
Benzhexol Hydrochloride,
Calcium Aurothiomalate,
Chlorocyclizine Hydrochloride,
Colloidal Calamine \ Complying with the standard defined in
Colloidal Kaolin \ the New Zealand Formulary:
Colloidal Zinc Oxide /
Diethazine Hydrochloride,
Dihydroergotamine Methanesulphonate,
Dihydrotachysterol or A.T. 10,
Diphenylhydramine Hydrochloride,
Elixir of Diphenylhydramine Hydrochloride,
Elixir of Diphenylhydramine Hydrochloride, Compound,
Elixir of Mepyramine Maleate,
Elixir of Promethazine Hydrochloride,
Emulsifying Waxes and other similar agents as are approved
from time to time by the Director-General of Health,
Ergometrine and its salts,
Ethopropazine Hydrochloride,
Extract of Ergot, Liquid, B.P. 1914,
Fehling’s Solution Nos. 1 and 2,
Globin Insulin,
Liver Extracts, including Vitamin B12 for administration by
injection,
Mereuramide with Theophylline,
Mersalyl with Theophylline,
Methaphenilene Hydrochloride,
Methyl-cellulose,
Methylergotamine Tartrate,
Mistura Aluminii Hydroxidi et Kaolini,
Oculentum Aureomycin,
Oculentum Ichthammol Compound, containing 2·5 per cent.
of Ichthammol with Zinc Oxide 2·5 per cent.,
Paramethadione,
Penicillin G-diethylaminoethyl ester hydriodide,
Penicillin-Procaine and such preparations thereof as are approved
from time to time by the Director-General of Health,
Phenindamine Tartrate,
Pitressin Tannate in oil for injection,
Silver Picrate,
Compound powder of silver picrate 1 per cent. (with Kaolin),
Suppositories of silver picrate 2 per cent.,
Sulphanilamide, its salts, compounds, and derivatives of sul-
phanilamide, their salts, pursuant to any one medical
prescription a supply sufficient for a period of seven days
commencing on the date of presentation of the prescription
and when prescribed for external or topical application
whether as an ointment, lotion, enema, suppository, or
other similar preparation, a supply not exceeding a total
quantity of 240 grains of one or more of the sulphonamides
(whether supplied in powdered form or with a suitable
vehicle). Compound sulphonamide suspension and such
proprietary combinations containing sulphonamides as are
approved from time to time by the Director-General of
Health,
Tablets of Magnesium Trisilicate and Dried Aluminium Hydrox-
ide Gel,
Tablets of Methoin,
Tablets of Methoin 0·10 G. with Phenobarbitone 0·02 G.,
Tablets of Phenytoin Sodium 1½ grains with Phenobarbitone
Sodium ¾ grain,
Tablets of Thyroid (fresh gland) allowed only when specifically
prescribed,
Thenylpyramine Hydrochloride,
Thonzylamine Hydrochloride,
Tripelennamine Hydrochloride,
Troxidone, known also as Trimethadione,
Water soluble analogues of Vitamin K as are approved from
time to time by the Director-General of Health,
Such unofficial combinations of two or more pharmaceutical
requirements as are approved from time to time by the
Director-General of Health.

5. Notwithstanding the provisions of clause 2 of this direction
   all materials which have been available at the cost of the Fund under
   the principal direction immediately before the commencement of this
   direction shall continue to be so available until the 31st day of
   March 1952.

6. Clause 10 of the principal direction is hereby revoked, and the
   following clause substituted therefor:—

“10. (1) Notwithstanding anything contained in the last
preceding clause, where in the opinion of the medical practitioner
attending any patient no danger is involved in the use of a phar-
maceutical requirement without medical supervision in the treat-
ment of the following chronic conditions—namely, asthma, diabetes,
epilepsy, hypothyroidism, pernicious anaemia, and such other
conditions as are approved for this purpose from time to time by
the Director-General of Health—a supply of that pharmaceutical
requirement up to a quantity sufficient to supply that patient for
a period not exceeding three months may be made, if the medical
practitioner has endorsed a prescription therefor with the words
‘Certified Extended Supply Condition,’ together with the period
for which the medication is to be supplied, not exceeding three
months supply in respect of any one prescription supplied to the
patient concerned.

“(2) In any such case a contractor on receiving a medical pres-
cription endorsed in accordance with subclause (1) of this clause may
supply those pharmaceutical requirements and claim on the Fund
accordingly.”

7. The following materials are included under paragraph (b) of
   clause 5 of the principal direction subject to the condition that they
   are supplied by a Hospital Board approved by the Director-General
   of Health under conditions that are defined from time to time by the
   Director-General of Health:—

(a) Aureomycin,
Chloramphenicol (Chloromycetin),
Hexamethonium Bromide (Vegolysen),
Hexamethonium Iodide (Hexathide),
Para-amino-salicylic acid and its salts,
Pentamethonium Bromide (Lytensium),
Pentamethonium Iodide (Antilussin).

(b) Such preparations of the materials mentioned in paragraph
(a) of this clause and such similar substances and pre-
parations as are approved from time to time by the
Director-General of Health.

8. The table of authorized midwifery pharmaceutical require-
   ments allowed under clause 14 of the principal direction is as
   follows:—

Column 1. Column 2.
Description of Material. Maximum Quantity for One
Patient.
Cyllin .. 4 oz.
Dettol or Pynol or Streph .. 4 oz.
Dettol Cream .. 1 tube (not to be supplied with
Dettol or Pynol or Streph).
Iodine, weak tincture of .. 2 oz.
Olive oil, or cotton-seed oil, or
peanut oil .. 3 oz.

9. The following notices and directions are hereby revoked—

Date of Notice or N.Z. Gazette.
Direction.
8 April 1947 .. .. No. 22 of 24 April 1947, at page 493.
7 October 1947 .. .. No. 59 of 9 October 1947, at page 1441.
26 October 1949 .. .. No. 61 of 3 November 1949, at page 2532.
26 October 1950 .. .. No. 66 of 26 October 1950, at page 1897.
29 May 1951 .. .. No. 43 of 31 May 1951, at page 784.

Dated at Wellington, this 9th day of October 1951.

J. R. MARSHALL, Minister of Health.

• Gazette, 30 January 1947, Vol. I, page 86.